Preparation and Evaluation of Glibenclamide-Loaded Biodegradable Nanoparticles

被引:10
作者
Behera, Amulyaratna [1 ]
Sahoo, Sunit Kumar [1 ]
机构
[1] Utkal Univ, Univ Dept Pharmaceut Sci, Vanivihar Bhubaneswar, Orissa, India
关键词
Poly (lactic-co-glycolic) acid; Nanoparticles; Glibenclamide; Transmission electron microscopy; Differential scanning calorimetry; DELIVERY;
D O I
10.4314/tjpr.v11i3.2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose: To formulate and evaluate glibenclamide (GB)-loaded poly(lactic-co-glycolic) acid (PLGA) nanoparticles (NPs) for controlled release. Methods: GB-loaded PLGA NPs were prepared by solvent evaporation technique using methanol/dichloromethane (2: 1) and characterized by transmission electron microscopy (TEM), and differential scanning calorimetry (DSC). The effect of stirring speed (250, 1000, 1500 and 2500 rpm) and drug: polymer ratio (1: 1, 1: 2, 1: 3 and 2: 1) on particle size, size distribution, zeta potential, drug loading, encapsulation efficiency and drug release was also studied. Results: Stable NPs were successfully prepared without any incompatibility, as indicated by TEM and DSC studies, respectively. As polymer and drug concentrations, and stirring speed increased, particle size, drug loading and encapsulation efficiency also increased. Increase in polymer concentration sustained drug release but reverse was obtained as drug concentration increased. Conclusion: Controlled release biodegradable glibenclamide NPs can be efficiently prepared by emulsification solvent evaporation method suitably modulating processing variables.
引用
收藏
页码:345 / 350
页数:6
相关论文
共 16 条
[1]  
ARNQVIST HJ, 1983, ANN CLIN RES, V15, P21
[2]   EXCESSIVE GLUCOSE-PRODUCTION, RATHER THAN INSULIN-RESISTANCE, ACCOUNTS FOR HYPERGLYCEMIA IN RECENT-ONSET STREPTOZOTOCIN-DIABETIC RATS [J].
BURCELIN, R ;
EDDOUKS, M ;
MAURY, J ;
KANDE, J ;
ASSAN, R ;
GIRARD, J .
DIABETOLOGIA, 1995, 38 (03) :283-290
[3]   CORRELATIONS BETWEEN INVITRO DISSOLUTION, INVIVO BIOAVAILABILITY AND HYPOGLYCEMIC EFFECT OF ORAL GLIBENCLAMIDE [J].
CHALK, JB ;
PATTERSON, M ;
SMITH, MT ;
EADIE, MJ .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 31 (02) :177-182
[4]  
Chen X., 2010, CHALLENGES NEW TECHN, P257
[5]   Modeling and comparison of dissolution profiles [J].
Costa, P ;
Manuel, J ;
Lobo, S .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 13 (02) :123-133
[6]   Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: Preparation, in vitro characterization and in vivo evaluation [J].
Cui, Fude ;
Shi, Kai ;
Zhang, Liqiang ;
Tao, Anjin ;
Kawashima, Yoshiaki .
JOURNAL OF CONTROLLED RELEASE, 2006, 114 (02) :242-250
[7]   Preparation and in vitro/in vivo evaluation of gliclazide loaded Eudragit nanoparticles as a sustained release carriers [J].
Devarajan, Padma V. ;
Sonavane, Ganeshchandra S. .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2007, 33 (02) :101-111
[8]  
Dora CP, 2010, ACTA POL PHARM, V67, P283
[9]  
DOUGLAS SJ, 1987, CRIT REV THER DRUG, V3, P233
[10]   THE EFFECT OF INVIVO DISPERSION AND GASTRIC-EMPTYING ON GLIBENCLAMIDE ABSORPTION FROM A NOVEL, RAPIDLY DISSOLVING CAPSULE FORMULATION [J].
GANLEY, JA ;
MCEWEN, J ;
CALVERT, RT ;
BARKER, MCJ .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1984, 36 (11) :734-739